Bis-quinolinium cyclophanes: A novel class of potent blockers of the apamin-sensitive Ca2+-activated K+ channel

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 1, 1997, Pages 7-10

  Campos Rosa, Joaquin ^a   Beckwith Hall, Bridgitte M ^a   Galanakis, Dimitrios ^a   Ganellin, C Robin ^a   Dunn, Philip M ^a   Jenkinson, Donald H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEQUALINIUM; MACROCYCLIC COMPOUND; POTASSIUM CHANNEL; QUATERNARY AMMONIUM DERIVATIVE; QUINOLINE DERIVATIVE; UCL 1530; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONDUCTANCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DESIGN; DRUG SYNTHESIS; IN VITRO STUDY; NONHUMAN; RAT; REACTION ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STRUCTURE ACTIVITY RELATION; SYMPATHETIC NERVE CELL;

EID: 0012586949     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(96)00568-9     Document Type: Article

References (21)

1. Haylett, D. G.; Jenkinson, D. H. In Potassium Channels; N. S. Cook, Ed.; Ellis Horwood Limited: Chichester, 1990; pp 70-95.
2. Lazdunski, M.; Romey, G.; Schmid-Antomarchi, H.; Renaud, J. F.; Mourre, C.; Hugues, M.; Fosset, M. Handbk. Exp. Pharmacol. 1988, 83, 135.
3. Renaud, J. F.; Desnuelle, C.; Schmid - Antomarchi, H.; Hugues, M.; Serratrice, G.; Lazdunski, M. Nature 1986, 319, 678.
4. Behrens, M. I.; Vergara, C. Am. J. Physiol. 1992, 263, C794.
5. Behrens, M. I.; Jalil, P.; Serani, A.; Vergara, F.; Alvarez, O. Muscle Nerve 1994, 17, 1264.
6. Banks, B. E. C.; Brown, C.; Burgess, G. M.; Burnstock, G.; Claret, M.; Cocks, T. M.; Jenkinson, D. H. Nature 1979, 282, 415.
7. Burgess, G. M.; Claret, M.; Jenkinson, D. H. J. Physiol. (Lond) 1981, 317, 67.
8. Lazdunski, M. Cell Calcium 1983, 4, 421.
9. Castle, N. A.; Haylett, D. G.; Morgan, J. M.; Jenkinson, D. H. Eur. J. Pharmacol. 1993, 236, 201.
10. Dunn, P. M. Eur. J. Pharmacol. 1994, 252, 189.
11. Galanakis, D.; Davis, C. A.; Del Rey Herrero, B.; Ganellin, C. R.; Dunn, P. M.; Jenkinson, D. H. Bioorg. Med. Chem. Lett. 1995, 5, 559.
12. Galanakis, D.; Calder, J. A. D.; Ganellin, C. R.; Owen, C. S.; Dunn, P. M. J. Med. Chem. 1995, 38, 3536.
13. Galanakis, D.; Ganellin, C. R.; Malik, S.; Dunn, P. M. J. Med. Chem. 1996, 39, 3592.
14. Campos Rosa, J.; Galanakis, D.; Ganellin, C. R.; Dunn, P. M. J. Med. Chem. 1996, 39, 4247.
15. Galanakis, D.; Davis, C. A.; Del Rey Herrero, B.; Ganellin, C. R.; Dunn, P. M.; Jenkinson, D. H. J. Med. Chem. 1995, 38, 595.
16. Galanakis, D.; Davis, C. A.; Ganellin, C. R.; Dunn, P. M. J. Med. Chem. 1996, 39, 359.
17. Hauser, C. R.; Reynolds, G. A. J. Org. Chem. 1950, 15, 1224.
18. Dunn, P. M.; Campos Rosa, J.; Beckwith-Hall, B.; Benton, D. C.; Ayalew, Y.; Ganellin, C. R.; Jenkinson, D. H. Br. J. Pharmacol. 1994, 112, 131P.
19. Dunn, P. M.; Benton, D. C. H.; Campos Rosa, J.; Ganellin, C. R.; Jenkinson, D. H. Br. J. Pharmacol. 1996, 117, 35.
20. Wadsworth, J. D. F.; Doorty, K. B.; Strong, P. N. J. Biol. Chem. 1994, 269, 18053.
21. Dunn, P. M.; Davis, C. A.; Ganellin, C. R.; Haylett, D. G.; Morgan, J. M.; Jenkinson, D. H. Br. J. Pharmacol. 1991, 104, 165P.